Literature DB >> 15353049

The course of C-reactive protein response in untreated upper respiratory tract infection.

Hasse Melbye1, Dag Hvidsten, Arne Holm, Sveine Arne Nordbø, Jan Brox.   

Abstract

BACKGROUND: High C-reactive protein (CRP) values are frequently found in patients with bacterial respiratory infection, and CRP testing has been shown to be useful in differentiating pneumonia from other respiratory infections. Raised CRP values may also be found in viral respiratory infection, and as a result there is a risk that antibiotics may be wrongly prescribed. AIMS: To describe the course of the CRP response during untreated upper respiratory tract infections and associations between the development of CRP values, erythrocyte sedimentation rate (ESR) and respiratory symptoms. DESIGN OF STUDY: Prospective study.
SETTING: Seven general practices in northern Norway.
METHOD: Patients with upper respiratory tract infection aged 16 years or over, who were not treated with antibiotics and who had been ill for no more than 3 days, were recruited. Microbiological examinations were undertaken, together with measurements of CRP, ESR and recording of symptoms daily during the first week of illness and on days 10, 14 and 21.
RESULTS: An aetiological agent was established in 23 of the 41 included subjects. These were: influenza A, influenza B, rhinovirus, and other agents. Among the 15 patients examined on both the second and the third day of illness, the median CRP value increased from 7-10 mg/l, and the mean value was from 19-24 mg/l between day 2 and day 3. Peak CRP values were reached on days 2 to 4. Higher CRP values were found in those infected with influenza A and B than in the other subjects (P <0.001). A CRP value >10 mg/l was found in 26 subjects during the first 7 days, compared to five subjects after 1 week. Evidence of a secondary infection with group A streptococci was found in two of these five subjects. The development of the symptoms of sore throat, fatigue, clamminess, and pain from muscles and joints followed a similar course as the CRP response, while stuffy nose, cough, sputum production, and dyspnoea tended to persist after the CRP values had approached the normal range.
CONCLUSION: A moderately elevated CRP value (10-60 mg/l) is a common finding in viral upper respiratory tract infection, with a peak during days 2-4 of illness. Moderately elevated CRP values cannot support a diagnosis of bacterial infection when the illness has lasted less than 7 days, but may indicate a complication of viral infection after a week.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15353049      PMCID: PMC1326064     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  16 in total

1.  C-reactive protein in respiratory virus infections.

Authors:  O Ruuskanen; A Putto; H Sarkkinen; O Meurman; K Irjala
Journal:  J Pediatr       Date:  1985-07       Impact factor: 4.406

Review 2.  Inflammatory responses in influenza A virus infection.

Authors:  I Julkunen; K Melén; M Nyqvist; J Pirhonen; T Sareneva; S Matikainen
Journal:  Vaccine       Date:  2000-12-08       Impact factor: 3.641

Review 3.  Influenza.

Authors:  N J Cox; K Subbarao
Journal:  Lancet       Date:  1999-10-09       Impact factor: 79.321

4.  Upper respiratory tract infections in general practice: diagnosis, antibiotic prescribing, duration of symptoms and use of diagnostic tests.

Authors:  Malin André; Inga Odenholt; Ake Schwan; Inge Axelsson; Margareta Eriksson; Mikael Hoffman; Sigvard Mölstad; Arne Runehagen; Cecilia Stålsby Lundborg; Rolf Wahlström
Journal:  Scand J Infect Dis       Date:  2002

5.  Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection.

Authors:  R M Hopstaken; J W Muris; J A Knottnerus; A D Kester; P E Rinkens; G J Dinant
Journal:  Br J Gen Pract       Date:  2003-05       Impact factor: 5.386

6.  Acute phase response of serum amyloid A protein and C reactive protein to the common cold and influenza.

Authors:  J T Whicher; R E Chambers; J Higginson; L Nashef; P G Higgins
Journal:  J Clin Pathol       Date:  1985-03       Impact factor: 3.411

7.  Diagnostic tools in respiratory tract infections: use and comparison with Finnish guidelines.

Authors:  Pekka Olavi Honkanen; Ulla-Maija Rautakorpi; Pentti Huovinen; Timo Klaukka; Erkki Palva; Risto Roine; Hannu Sarkkinen; Helena Varonen; Marjukka Mäkelä
Journal:  Scand J Infect Dis       Date:  2002

8.  [C-reactive protein, SR and white blood cell count in acute lower respiratory tract diseases. The usefulness of blood tests in diagnosis of pneumonia].

Authors:  N Ritland; H Melbye
Journal:  Tidsskr Nor Laegeforen       Date:  1991-08-10

9.  The diagnosis of adult pneumonia in general practice. The diagnostic value of history, physical examination and some blood tests.

Authors:  H Melbye; B Straume; U Aasebø; J Brox
Journal:  Scand J Prim Health Care       Date:  1988-05       Impact factor: 2.581

10.  Sinusitis in the common cold.

Authors:  T Puhakka; M J Mäkelä; A Alanen; T Kallio; L Korsoff; P Arstila; M Leinonen; M Pulkkinen; J Suonpää; J Mertsola; O Ruuskanen
Journal:  J Allergy Clin Immunol       Date:  1998-09       Impact factor: 10.793

View more
  31 in total

1.  C-reactive protein values in viral respiratory infections.

Authors:  Johannes C van der Wouden; Miriam Monteny; Marjolein Y Berger
Journal:  Br J Gen Pract       Date:  2005-01       Impact factor: 5.386

2.  Insight into infection-mediated prostate damage: Contrasting patterns of C-reactive protein and prostate-specific antigen levels during infection.

Authors:  Melissa Milbrandt; Anke C Winter; Remington L Nevin; Ratna Pakpahan; Gary Bradwin; Angelo M De Marzo; Debra J Elliott; Charlotte A Gaydos; William B Isaacs; William G Nelson; Nader Rifai; Lori J Sokoll; Jonathan M Zenilman; Elizabeth A Platz; Siobhan Sutcliffe
Journal:  Prostate       Date:  2017-07-12       Impact factor: 4.104

3.  Ethnicity, obesity and the metabolic syndrome: implications on assessing risk and targeting intervention.

Authors:  Mark D Deboer
Journal:  Expert Rev Endocrinol Metab       Date:  2011-03

Review 4.  Inflammatory Biomarkers During Bacterial Acute Rhinosinusitis.

Authors:  Timo J Autio; Timo Koskenkorva; Petri Koivunen; Olli-Pekka Alho
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-21       Impact factor: 4.806

5.  Administering intravenous immunoglobulin during infection is associated with infusion reactions in selected patients.

Authors:  S Khan; M Abuzakouk; P C Doré; W A C Sewell
Journal:  Ir J Med Sci       Date:  2010-12-07       Impact factor: 1.568

6.  Ability among adolescents for the metabolic syndrome to predict elevations in factors associated with type 2 diabetes and cardiovascular disease: data from the national health and nutrition examination survey 1999-2006.

Authors:  Mark D DeBoer; Matthew J Gurka
Journal:  Metab Syndr Relat Disord       Date:  2010-08       Impact factor: 1.894

7.  C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H1N1 influenza A virus infection.

Authors:  Ofer Zimmerman; Ori Rogowski; Galit Aviram; Michal Mizrahi; David Zeltser; Dan Justo; Esther Dahan; Roy Arad; Oholi Touvia; Luba Tau; Jalal Tarabeia; Shlomo Berliner; Yael Paran
Journal:  BMC Infect Dis       Date:  2010-10-04       Impact factor: 3.090

8.  Bacterial superinfection in upper respiratory tract infections estimated by increases in CRP values: a diagnostic follow-up in primary care.

Authors:  Heide Lingard; Sonja Zehetmayer; Manfred Maier
Journal:  Scand J Prim Health Care       Date:  2008       Impact factor: 2.581

9.  Diagnostic accuracy of C-reactive protein for intraabdominal infections after colorectal resections.

Authors:  Hartwig Kørner; Hans Jørgen Nielsen; Jon Arne Søreide; Bjørn S Nedrebø; Kjetil Søreide; Jens C Knapp
Journal:  J Gastrointest Surg       Date:  2009-05-29       Impact factor: 3.452

10.  Male fetus susceptibility to maternal inflammation: C-reactive protein and brain development.

Authors:  Sharon K Hunter; M Camille Hoffman; Angelo D'Alessandro; Kathleen Noonan; Anna Wyrwa; Robert Freedman; Amanda J Law
Journal:  Psychol Med       Date:  2019-12-02       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.